Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19)

Clinical trial NCT04760743 · COMPLETED

Trial details

NCT number: NCT04760743
Sponsor: SK Bioscience Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 (Healthy Volunteers)

Start date: 2020-12-17
Primary completion: 2021-04-02
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.